Republic of Korea vs United Kingdom of Great Britain and Northern Ireland: Prevalence rate of hypertension in women aged 30-79

Republic of Korea
21.2
in 2019
United Kingdom of Great Britain and Northern Ireland
23
in 2019
Republic of Korea rank
191st
United Kingdom of Great Britain and Northern Ireland rank
189th

Prevalence rate of hypertension in women aged 30-79 over time

  • Republic of Korea
  • United Kingdom of Great Britain and Northern Ireland
0102030199020042019

How they compare

United Kingdom of Great Britain and Northern Ireland currently reports 23 against 21.2 in Republic of Korea, a difference of 1.8.

That makes United Kingdom of Great Britain and Northern Ireland's figure about 1.1 times Republic of Korea's.

Across all 30 years both countries report, United Kingdom of Great Britain and Northern Ireland has been ahead every year.

Republic of Korea ranks 191st and United Kingdom of Great Britain and Northern Ireland ranks 189th of 195 countries.

United Kingdom of Great Britain and Northern Ireland has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Republic of Korea United Kingdom of Great Britain and Northern Ireland Difference Ahead
1990s 29.23 32.31 3.08 United Kingdom of Great Britain and Northern Ireland
2000s 25.36 27.97 2.61 United Kingdom of Great Britain and Northern Ireland
2010s 22.47 24.44 1.97 United Kingdom of Great Britain and Northern Ireland

Averages of every year both report within each decade.

Frequently asked questions

Which has higher prevalence rate of hypertension in women aged 30-79, Republic of Korea or United Kingdom of Great Britain and Northern Ireland?
United Kingdom of Great Britain and Northern Ireland, at 23 against 21.2 in Republic of Korea as of 2019.
What is the difference in prevalence rate of hypertension in women aged 30-79 between Republic of Korea and United Kingdom of Great Britain and Northern Ireland?
1.8, with United Kingdom of Great Britain and Northern Ireland ahead.
How many years of comparable data are there for Republic of Korea and United Kingdom of Great Britain and Northern Ireland?
30 years are reported by both, from 1990 to 2019.
How do Republic of Korea and United Kingdom of Great Britain and Northern Ireland rank globally for prevalence rate of hypertension in women aged 30-79?
Republic of Korea ranks 191st and United Kingdom of Great Britain and Northern Ireland ranks 189th of 195 countries.
Where does this data come from?
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Republic of Korea vs United Kingdom of Great Britain and Northern Ireland: Prevalence rate of hypertension in women aged 30-79. Statizoid, drawing on World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data. Retrieved 04 September 2026, from https://gender.statizoid.com/compare/women-high-blood-pressure/korea-rep/united-kingdom/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://gender.statizoid.com/compare/women-high-blood-pressure/korea-rep/united-kingdom/">Republic of Korea vs United Kingdom of Great Britain and Northern Ireland: Prevalence rate of hypertension in women aged 30-79</a> — Statizoid

About this data

Indicator
Prevalence rate of hypertension in women aged 30-79
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
195 places, 5,850 data points, 1990–2019
Last refreshed

Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.